MORETTA, ALESSANDRO
MORETTA, ALESSANDRO
100008 - Dipartimento di medicina sperimentale
2B4 functions as a co-receptor in human NK cell activation
2000-01-01 Sivori, Simona; Moretta, Lorenzo; Falco, M.; Marcenaro, Emanuela; Biassoni, R.; Bottino, Cristina; Moretta, L.; Moretta, Alessandro
A high-resolution view of NK-cell receptors: structure and function.
2000-01-01 Colonna, M; Moretta, Alessandro; Vély, F; Vivier, E.
A monoclonal anti-DC1 antibody selectivity inhibits the generation of effector T cells mediating specific cytolytic activity.
1982-01-01 Corte, G; Moretta, Alessandro; Cosulich, Me; Ramarli, D; Bargellesi, A.
A monoclonal antibody specific for a common determinant of the human T cell receptor gamma/delta directly activates CD3+WT31- lymphocytes to express their functional program(s).
1988-01-01 Ciccone, Ermanno; Ferrini, S; Bottino, Cristina; Viale, O; Prigione, I; Pantaleo, G; Tambussi, G; Moretta, Alessandro; Moretta, Lorenzo
A new mechanism of resistance to NK cell attack in melanoma
2012-01-01 M., Vitale; M., Balsamo; M., Parodi; Pietra, Gabriella; C., Manzini; Moretta, Alessandro; W., Vermi; F., Facchetti; Moretta, Lorenzo; Mingari, MARIA CRISTINA
A novel 120-kD surface antigen expressed by a subset of human lymphocytes. Evidence that lymphokine-activated killer cells express this molecule and use it in their effector function.
1987-01-01 Zocchi, Mr; Bottino, Cristina; Ferrini, S; Moretta, Alessandro; Moretta, Lorenzo
A novel KIR-associated function: evidence that CpG DNA uptake and shuttling to early endosomes is mediated by KIR3DL2
2010-01-01 Sivori, Simona; Falco, M.; Carlomagno, Simona; Romeo, E.; Soldani, C.; Bensussan, A.; Viola, A.; Moretta, Alessandro; Moretta, Lorenzo
A novel mechanism of antitumor response involving the expansion of CD3+/CD56+ large granular lymphocytes triggered by a tumor-expressed activating ligand.
2002-01-01 Costello, Rt; Sivori, Simona; Mallet, F; Sainty, D; Arnoulet, C; Reviron, D; Gastaut, Ja; Moretta, Alessandro; Olive, D.
A novel surface antigen expressed by a subset of human CD3- CD16+ natural killer cells. Role in cell activation and regulation of cytolytic function.
1990-01-01 Moretta, Alessandro; Tambussi, G; Bottino, Cristina; Tripodi, G; Merli, A; Ciccone, Ermanno; Pantaleo, G; Moretta, Lorenzo
A novel surface molecule homologous to the p58/p50 family of receptors is selectively expressed on a subset of human natural killer cells and induces both triggering of cell functions and proliferation.
1996-01-01 Bottino, Cristina; Sivori, Simona; Vitale, M; Cantoni, Claudia; Falco, M; Pende, D; Morelli, L; Augugliaro, R; Semenzato, G; Biassoni, R; Moretta, Alessandro; Moretta, Lorenzo
Activating and inhibitory killer immunoglobulin-like receptors (KIR) in haploidentical haemopoietic stem cell transplantation to cure high-risk leukaemias.
2009-01-01 Moretta, Alessandro; Pende, D; Locatelli, F; Moretta, Lorenzo
Activating KIRs and NKG2C in viral infections: Toward NK cell memory?
2015-01-01 DELLA CHIESA, Mariella; Sivori, Simona; Carlomagno, Simona; Moretta, Lorenzo; Moretta, Alessandro
Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis
2001-01-01 Moretta, Alessandro; Bottino, Cristina; Vitale, M; Pende, D; Cantoni, Claudia; Mingari, MARIA CRISTINA; Biassoni, R; Moretta, Lorenzo
Activation of human NK cells by plasmacytoid dendritic cells and its modulation by CD4 + T helper cells and CD4 + CD25hi T regulatory cells
2005-01-01 Romagnani, C.; DELLA CHIESA, Mariella; Kohler, S.; Moewes, B.; Radbruch, A.; Moretta, Alessandro; Moretta, Lorenzo; Thiel, A.
Activity and phenotype of natural killer cells in peptide transporter (TAP)-deficient patients (type I bare lymphocyte syndrome).
1998-01-01 Zimmer, J; Donato, L; Hanau, D; Cazenave, Jp; Tongio, Mm; Moretta, Alessandro; de la Salle, H.
Adaptor protein 3 complex deficiency causes innate immunity defects
2008-01-01 S., Parolini; G., Tabellini; Marcenaro, Emanuela; R., Badolato; L., Notarangelo; F., Facchetti; W., Vermi; M., Benassi; Millo, Romano; Moretta, Alessandro
Aegean reflections on innate immunity
2013-01-01 Hajishengallis, G; Mantovani, A; Moretta, Alessandro; Lambris, J. D.
Alloantigen recognition by two human natural killer cell clones is associated with HLA-C or a closely linked gene.
1992-01-01 Colonna, M; Spies, T; Strominger, Jl; Ciccone, E; Moretta, Alessandro; Moretta, Lorenzo; Pende, D; Viale, O.
Allogeneic mixed lymphocyte reactions in humans: pretreatment of either the stimulator or the responder cell population with monoclonal anti-Ia antibodies leads to an inhibition of cell proliferation.
1981-01-01 Accolla, Rs; Moretta, Alessandro; Cerottini, Jc
Alloreactive natural killer cells in targeting high-risk leukaemias.
2008-01-01 Moretta, Alessandro; Locatelli, F; Moretta, Lorenzo
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 2B4 functions as a co-receptor in human NK cell activation | 1-gen-2000 | Sivori, Simona; Moretta, Lorenzo; Falco, M.; Marcenaro, Emanuela; Biassoni, R.; Bottino, Cristina; Moretta, L.; Moretta, Alessandro | |
| A high-resolution view of NK-cell receptors: structure and function. | 1-gen-2000 | Colonna, M; Moretta, Alessandro; Vély, F; Vivier, E. | |
| A monoclonal anti-DC1 antibody selectivity inhibits the generation of effector T cells mediating specific cytolytic activity. | 1-gen-1982 | Corte, G; Moretta, Alessandro; Cosulich, Me; Ramarli, D; Bargellesi, A. | |
| A monoclonal antibody specific for a common determinant of the human T cell receptor gamma/delta directly activates CD3+WT31- lymphocytes to express their functional program(s). | 1-gen-1988 | Ciccone, Ermanno; Ferrini, S; Bottino, Cristina; Viale, O; Prigione, I; Pantaleo, G; Tambussi, G; Moretta, Alessandro; Moretta, Lorenzo | |
| A new mechanism of resistance to NK cell attack in melanoma | 1-gen-2012 | M., Vitale; M., Balsamo; M., Parodi; Pietra, Gabriella; C., Manzini; Moretta, Alessandro; W., Vermi; F., Facchetti; Moretta, Lorenzo; Mingari, MARIA CRISTINA | |
| A novel 120-kD surface antigen expressed by a subset of human lymphocytes. Evidence that lymphokine-activated killer cells express this molecule and use it in their effector function. | 1-gen-1987 | Zocchi, Mr; Bottino, Cristina; Ferrini, S; Moretta, Alessandro; Moretta, Lorenzo | |
| A novel KIR-associated function: evidence that CpG DNA uptake and shuttling to early endosomes is mediated by KIR3DL2 | 1-gen-2010 | Sivori, Simona; Falco, M.; Carlomagno, Simona; Romeo, E.; Soldani, C.; Bensussan, A.; Viola, A.; Moretta, Alessandro; Moretta, Lorenzo | |
| A novel mechanism of antitumor response involving the expansion of CD3+/CD56+ large granular lymphocytes triggered by a tumor-expressed activating ligand. | 1-gen-2002 | Costello, Rt; Sivori, Simona; Mallet, F; Sainty, D; Arnoulet, C; Reviron, D; Gastaut, Ja; Moretta, Alessandro; Olive, D. | |
| A novel surface antigen expressed by a subset of human CD3- CD16+ natural killer cells. Role in cell activation and regulation of cytolytic function. | 1-gen-1990 | Moretta, Alessandro; Tambussi, G; Bottino, Cristina; Tripodi, G; Merli, A; Ciccone, Ermanno; Pantaleo, G; Moretta, Lorenzo | |
| A novel surface molecule homologous to the p58/p50 family of receptors is selectively expressed on a subset of human natural killer cells and induces both triggering of cell functions and proliferation. | 1-gen-1996 | Bottino, Cristina; Sivori, Simona; Vitale, M; Cantoni, Claudia; Falco, M; Pende, D; Morelli, L; Augugliaro, R; Semenzato, G; Biassoni, R; Moretta, Alessandro; Moretta, Lorenzo | |
| Activating and inhibitory killer immunoglobulin-like receptors (KIR) in haploidentical haemopoietic stem cell transplantation to cure high-risk leukaemias. | 1-gen-2009 | Moretta, Alessandro; Pende, D; Locatelli, F; Moretta, Lorenzo | |
| Activating KIRs and NKG2C in viral infections: Toward NK cell memory? | 1-gen-2015 | DELLA CHIESA, Mariella; Sivori, Simona; Carlomagno, Simona; Moretta, Lorenzo; Moretta, Alessandro | |
| Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis | 1-gen-2001 | Moretta, Alessandro; Bottino, Cristina; Vitale, M; Pende, D; Cantoni, Claudia; Mingari, MARIA CRISTINA; Biassoni, R; Moretta, Lorenzo | |
| Activation of human NK cells by plasmacytoid dendritic cells and its modulation by CD4 + T helper cells and CD4 + CD25hi T regulatory cells | 1-gen-2005 | Romagnani, C.; DELLA CHIESA, Mariella; Kohler, S.; Moewes, B.; Radbruch, A.; Moretta, Alessandro; Moretta, Lorenzo; Thiel, A. | |
| Activity and phenotype of natural killer cells in peptide transporter (TAP)-deficient patients (type I bare lymphocyte syndrome). | 1-gen-1998 | Zimmer, J; Donato, L; Hanau, D; Cazenave, Jp; Tongio, Mm; Moretta, Alessandro; de la Salle, H. | |
| Adaptor protein 3 complex deficiency causes innate immunity defects | 1-gen-2008 | S., Parolini; G., Tabellini; Marcenaro, Emanuela; R., Badolato; L., Notarangelo; F., Facchetti; W., Vermi; M., Benassi; Millo, Romano; Moretta, Alessandro | |
| Aegean reflections on innate immunity | 1-gen-2013 | Hajishengallis, G; Mantovani, A; Moretta, Alessandro; Lambris, J. D. | |
| Alloantigen recognition by two human natural killer cell clones is associated with HLA-C or a closely linked gene. | 1-gen-1992 | Colonna, M; Spies, T; Strominger, Jl; Ciccone, E; Moretta, Alessandro; Moretta, Lorenzo; Pende, D; Viale, O. | |
| Allogeneic mixed lymphocyte reactions in humans: pretreatment of either the stimulator or the responder cell population with monoclonal anti-Ia antibodies leads to an inhibition of cell proliferation. | 1-gen-1981 | Accolla, Rs; Moretta, Alessandro; Cerottini, Jc | |
| Alloreactive natural killer cells in targeting high-risk leukaemias. | 1-gen-2008 | Moretta, Alessandro; Locatelli, F; Moretta, Lorenzo |